Zhu YH - Search Results

1

Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration.

Li HJ, Du JZ, Liu J, Du XJ, Shen S, Zhu YH, Wang X, Ye X, Nie S, Wang J. Li HJ, et al. Among authors: zhu yh. ACS Nano. 2016 Jul 26;10(7):6753-61. doi: 10.1021/acsnano.6b02326. Epub 2016 Jun 3. ACS Nano. 2016. PMID: 27244096

2

Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds.

Sun TM, Wang YC, Wang F, Du JZ, Mao CQ, Sun CY, Tang RZ, Liu Y, Zhu J, Zhu YH, Yang XZ, Wang J. Sun TM, et al. Among authors: zhu yh, zhu j. Biomaterials. 2014 Jan;35(2):836-45. doi: 10.1016/j.biomaterials.2013.10.011. Epub 2013 Oct 18. Biomaterials. 2014. PMID: 24144908

3

Differential anticancer drug delivery with a nanogel sensitive to bacteria-accumulated tumor artificial environment.

Xiong MH, Bao Y, Du XJ, Tan ZB, Jiang Q, Wang HX, Zhu YH, Wang J. Xiong MH, et al. Among authors: zhu yh. ACS Nano. 2013 Dec 23;7(12):10636-45. doi: 10.1021/nn403146t. Epub 2013 Nov 18. ACS Nano. 2013. PMID: 24200225

4

Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy.

Yang XZ, Du XJ, Liu Y, Zhu YH, Liu YZ, Li YP, Wang J. Yang XZ, et al. Among authors: zhu yh. Adv Mater. 2014 Feb 12;26(6):931-6. doi: 10.1002/adma.201303360. Epub 2013 Dec 16. Adv Mater. 2014. PMID: 24338636

5

Cationic lipid-assisted polymeric nanoparticle mediated GATA2 siRNA delivery for synthetic lethal therapy of KRAS mutant non-small-cell lung carcinoma.

Shen S, Mao CQ, Yang XZ, Du XJ, Liu Y, Zhu YH, Wang J. Shen S, et al. Among authors: zhu yh. Mol Pharm. 2014 Aug 4;11(8):2612-22. doi: 10.1021/mp400714z. Epub 2014 Feb 20. Mol Pharm. 2014. PMID: 24521262

6

Delivery of antibiotics with polymeric particles.

Xiong MH, Bao Y, Yang XZ, Zhu YH, Wang J. Xiong MH, et al. Among authors: zhu yh. Adv Drug Deliv Rev. 2014 Nov 30;78:63-76. doi: 10.1016/j.addr.2014.02.002. Epub 2014 Feb 16. Adv Drug Deliv Rev. 2014. PMID: 24548540 Review.

7

Matrix metalloproteinase 2-responsive micelle for siRNA delivery.

Wang HX, Yang XZ, Sun CY, Mao CQ, Zhu YH, Wang J. Wang HX, et al. Among authors: zhu yh. Biomaterials. 2014 Aug;35(26):7622-34. doi: 10.1016/j.biomaterials.2014.05.050. Epub 2014 Jun 11. Biomaterials. 2014. PMID: 24929619

8

ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.

Dou S, Yang XZ, Xiong MH, Sun CY, Yao YD, Zhu YH, Wang J. Dou S, et al. Among authors: zhu yh. Adv Healthc Mater. 2014 Nov;3(11):1792-803. doi: 10.1002/adhm.201400037. Epub 2014 Jun 20. Adv Healthc Mater. 2014. PMID: 24947820

9

Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.

Liu Y, Zhu YH, Mao CQ, Dou S, Shen S, Tan ZB, Wang J. Liu Y, et al. Among authors: zhu yh. J Control Release. 2014 Oct 28;192:114-21. doi: 10.1016/j.jconrel.2014.07.001. Epub 2014 Jul 10. J Control Release. 2014. PMID: 25016158

10

Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.

Li SY, Sun R, Wang HX, Shen S, Liu Y, Du XJ, Zhu YH, Jun W. Li SY, et al. Among authors: zhu yh. J Control Release. 2015 May 10;205:7-14. doi: 10.1016/j.jconrel.2014.11.011. Epub 2014 Nov 15. J Control Release. 2015. PMID: 25445694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

747 results

Search Page

Filters